Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

Cited by (1,006)

Items 201–300 of 1,006

1. Genetics of Alzheimer's disease: new evidences for an old hypothesis?
   Jean‐Charles Lambert, Philippe Amouyel · 2011 · Current Opinion in Genetics & Development
2. Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature
   Richard Lathe, Alexandra A. Tsitrina, Yuri V. Kotelevtsev · 2014 · BMC Geriatrics
3. Target Identification for CNS Diseases by Transcriptional Profiling
   C. Anthony Altar, Marquis P. Vawter, Stephen D. Ginsberg · 2008 · Neuropsychopharmacology
4. No paradox, no progress: inverse cancer comorbidity in people with other complex diseases
   Rafael Tabarés‐Seisdedos, Nancy Dumont, Anaı̈s Baudot, José M Valderas, Joan Climent, Alfonso Valencia, Benedicto Crespo‐Facorro, Eduard Vieta, Manuel Gómez-Beneyto, Salvador Martı́nez et al. · 2011 · The Lancet Oncology
5. On Jim Watson's APOE status: genetic information is hard to hide
   Dale R. Nyholt, Chang‐En Yu, Peter M. Visscher · 2008 · European Journal of Human Genetics
6. The IL-1 family cytokines and receptors in autoimmune diseases
   Paola Migliorini, Paola Italiani, Federico Pratesi, Ilaria Puxeddu, Diana Boraschi · 2020 · Autoimmunity Reviews
7. Genetics of Alzheimer's disease: recent advances
   Avramopoulos, Dimitrios · 2009 · Genome Medicine
8. Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer’s brains
   Ando, Kunie, Brion, Jean-Pierre, Stygelbout, Virginie, Suain, Valérie, Authelet, Michèle, Dedecker, Robert, Chanut, Anaïs, Lacor, Pascale, Lavaur, Jérémie, Sazdovitch, Véronique et al. · 2013 · Acta Neuropathologica
9. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective
   Rahman, Md. Rezanur, Islam, Tania, Zaman, Toyfiquz, Shahjaman, Md., Karim, Md. Rezaul, Huq, Fazlul, Quinn, Julian M.W., Holsinger, R.M. Damian, Gov, Esra, Moni, Mohammad Ali · 2020 · Genomics
10. Correlatedz-Values and the Accuracy of Large-Scale Statistical Estimates
    Bradley Efron · 2010 · Journal of the American Statistical Association
11. Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells
    Alison E. Mungenast, Sandra Siegert, Li‐Huei Tsai · 2015 · Molecular and Cellular Neuroscience
12. Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes
    Mireia Vilardell, Axel Rasche, Anja Thormann, Elisabeth Maschke-Dutz, Luis Alberto Pérez Jurado, Hans Lehrach, Ralf Herwig · 2011 · BMC Genomics
13. Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta‐analysis
    Noriko Fukumoto, Takashi Fujii, Onofre Combarros, M. Ilyas Kamboh, Shin-Jen Tsai, Sachio Matsushita, Benedetta Nacmias, David E. Comings, Humberto Arboleda, Martin Ingelsson et al. · 2009 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
14. The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?
    Kehoe, Patrick Gavin · 2018 · Journal of Alzheimer’s Disease
15. Cystatin C in aging and in Alzheimer’s disease
    Mathews, Paul M., Levy, Efrat · 2016 · Ageing Research Reviews
16. Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer’s disease
    Frieden, Carl, Garai, Kanchan · 2012 · Proceedings of the National Academy of Sciences
17. Integrated systems analysis reveals a molecular network underlying autism spectrum disorders
    Li, Jingjing, Shi, Minyi, Ma, Zhihai, Zhao, Shuchun, Euskirchen, Ghia, Ziskin, Jennifer, Urban, Alexander, Hallmayer, Joachim, Snyder, Michael · 2014 · Molecular Systems Biology
18. Exercise, APOE genotype, and the evolution of the human lifespan
    David A. Raichlen, Gene E. Alexander · 2014 · Trends in Neurosciences
19. How to Use an Article About Genetic Association
    John Attia, John P. A. Ioannidis, Ammarin Thakkinstian, Mark McEvoy, Rodney J. Scott, Cosetta Minelli, John Russell Thompson, Claire Infante‐Rivard, Gordon Henry Guyatt · 2009 · JAMA
20. Genome-Wide Scan of Copy Number Variation in Late-Onset Alzheimer's Disease
    Erin L. Heinzen, Anna C. Need, Kathleen M. Hayden, Ornit Chiba‐Falek, Allen D. Roses, Warren J. Strittmatter, James R. Burke, Christine Marie Hulette, Kathleen Anne Welsh-Bohmer, David B. Goldstein · 2010 · Journal of Alzheimer s Disease
21. Genetic association studies in patients with traumatic brain injury
    Efthimios Dardiotis, Kostas N. Fountas, Maria Dardioti, Georgia Xiromerisiou, Eftychia Z. Kapsalaki, Αναστασία Τάσιου, Georgios M. Hadjigeorgiou · 2009 · Neurosurgical FOCUS
22. The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review
    Kexin Wen, Jelena Milić, Bassem F. El‐Khodor, Klodian Dhana, Jana Nano, Tammy Pulido, Bledar Kraja, Asija Začiragić, Wichor Matthijs Bramer, John Troup et al. · 2016 · PLoS ONE
23. The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects
    Sleegers, Kristel, Lambert, Jean-Charles, Bertram, Lars, Cruts, Marc, Amouyel, Philippe, Van Broeckhoven, Christine · 2010 · Trends in Genetics
24. Targeting TNF: a therapeutic strategy for Alzheimer's disease
    Xin Cheng, Yong Shen, Rena Li · 2014 · Drug Discovery Today
25. Examination of the current top candidate genes for AD in a genome-wide association study
    Feulner, T M, Laws, S M, Friedrich, P, Wagenpfeil, S, Wurst, S H R, Riehle, C, Kuhn, K A, Krawczak, M, Schreiber, S, Nikolaus, S et al. · 2010 · Molecular Psychiatry
26. SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease
    Cruchaga, Carlos, Kauwe, John S. K., Mayo, Kevin, Spiegel, Noah, Bertelsen, Sarah, Nowotny, Petra, Shah, Aarti R., Abraham, Richard, Hollingworth, Paul, Harold, Denise et al. · 2010 · PLoS Genetics
27. Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies
    Junjun Wang, Qingyun Liu, Shuai Yuan, Weijia Xie, Yuan Liu, Ying Xiang, Na Wu, Long Wu, Xiangyu Ma, Tongjian Cai et al. · 2017 · Scientific Reports
28. Post-Stroke Cognitive Impairment: A Review Focusing on Molecular Biomarkers
    Xinxin Zhang, Xia Bi · 2020 · Journal of Molecular Neuroscience
29. Neuronal death in Alzheimer’s disease and therapeutic opportunities
    Rossen Donev, Martin V. Kolev, Bruno Millet, Johannes Thome · 2009 · Journal of Cellular and Molecular Medicine
30. Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus
    Wei‐Jen Tang · 2015 · Trends in Endocrinology and Metabolism
31. Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study
    Joseph Hyungwoo Lee · 2008 · Archives of Neurology
32. SynaptomeDB: an ontology-based knowledgebase for synaptic genes
    Pirooznia, Mehdi, Wang, Tao, Avramopoulos, Dimitrios, Valle, David, Thomas, Gareth, Huganir, Richard L., Goes, Fernando S., Potash, James B., Zandi, Peter P. · 2012 · Bioinformatics
33. Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence
    Xiangyu Ma, Ben Zhang, Wei Zheng · 2013 · Gut
34. Interactome mapping suggests new mechanistic details underlying Alzheimer's disease
    Montserrat Soler‐López, Andreas Zanzoni, Ricart Lluís, Ulrich Stelzl, Patrick Aloy · 2010 · Genome Research
35. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease
    Lim, Yen Ying, Villemagne, Victor L., Laws, Simon M., Ames, David, Pietrzak, Robert H., Ellis, Kathryn A., Harrington, Karra D., Bourgeat, Pierrick, Salvado, Olivier, Darby, David et al. · 2013 · Neurobiology of Aging
36. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer’s disease
    Berchtold, Nicole C., Sabbagh, Marwan N., Beach, Thomas G., Kim, Ronald C., Cribbs, David H., Cotman, Carl W. · 2014 · Neurobiology of Aging
37. Role of Epigenetics in Alzheimer ‘S and Parkinson‘S Disease
    John B. Kwok · 2010 · Epigenomics
38. Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs
    Parcon, Paul A., Balasubramaniam, Meenakshisundaram, Ayyadevara, Srinivas, Jones, Richard A., Liu, Ling, Shmookler Reis, Robert J., Barger, Steven W., Mrak, Robert E., Griffin, W. Sue T. · 2018 · Alzheimer's & Dementia
39. Tissue-Specific Effects of Loss of Estrogen during Menopause and Aging
    Korinna Wend, Peter Wend, Susan A. Krum · 2012 · Frontiers in Endocrinology
40. Connectomic Intermediate Phenotypes for Psychiatric Disorders
    Alex Fornito, Edward Thomas Bullmore · 2012 · Frontiers in Psychiatry
41. Role of Cholesterol in APP Metabolism and Its Significance in Alzheimer’s Disease Pathogenesis
    Mahua Maulik, David A. Westaway, Jack H. Jhamandas, Satyabrata Kar · 2012 · Molecular Neurobiology
42. Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele
    Sana Suri, Clare E. Mackay, Michael E. Kelly, Michael A. Germuska, Elizabeth M. Tunbridge, Giovanni Battista Frisoni, Paul McMahan Matthews, Klaus P. Ebmeier, Daniel Peter Bulte, Nicola Filippini · 2014 · Alzheimer s & Dementia
43. Leveraging preclinical models for the development of Alzheimer disease therapeutics
    Kimberly A. Scearce-Levie, Pascal E. Sanchez, Joseph W. Lewcock · 2020 · Nature Reviews Drug Discovery
44. Non-coding variability at the APOE locus contributes to the Alzheimer’s risk
    Zhou, Xiaopu, Chen, Yu, Mok, Kin Y., Kwok, Timothy C. Y., Mok, Vincent C. T., Guo, Qihao, Ip, Fanny C., Chen, Yuewen, Mullapudi, Nandita, Alzheimer’s Disease Neuroimaging Initiative et al. · 2019 · Nature Communications
45. Genetically modified pig models for neurodegenerative disorders
    Ida E. Holm, Aage Kristian Olsen Alstrup, Yonglun Luo · 2015 · The Journal of Pathology
46. Genetics of neurodegenerative diseases: an overview
    Lasse Pihlstrøm, Sarah Wiethoff, Henry Houlden · 2017 · Handbook of clinical neurology
47. Association between the interleukin-1β polymorphisms and Alzheimer's disease: A systematic review and meta-analysis
    Danilo Di Bona, Antonella Plaia, Sonya Vasto, Luca Cavallone, Francesco Lescai, Claudio Franceschi, Federico Licastro, Giuseppina Colonna‐Romano, Domenico Lio, Giuseppina Candore et al. · 2008 · Brain Research Reviews
48. One-Carbon Metabolism and Alzheimers Disease: Focus on Epigenetics
    Fabio Coppedè · 2010 · Current Genomics
49. Expression profiling of mouse subplate reveals a dynamic gene network and disease association with autism and schizophrenia
    Anna Hoerder‐Suabedissen, Franziska M. Oeschger, Michelle L. Krishnan, T. Grant Belgard, Wei Zhi Wang, Sheena Lee, Caleb Webber, Enrico G. Petretto, Anthony David Edwards, Zoltán Molnár · 2013 · Proceedings of the National Academy of Sciences
50. Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies
    Siontis, Konstantinos C M, Patsopoulos, Nikolaos A, Ioannidis, John P A · 2010 · European Journal of Human Genetics
51. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer’s disease
    Frank Dohler, Diego Sepúlveda Falla, Susanne Krasemann, Hermann C. Altmeppen, Hartmut Schlüter, Diana Hildebrand, Inga Zerr, Jakob Matschke, Markus Glatzel · 2014 · Brain
52. Analyzing the genes related to Alzheimer’s disease via a network and pathway-based approach
    Yan-Shi Hu, Juncai Xin, Ying Chuan Hu, Lei Zhang, Ju Wang · 2017 · Alzheimer s Research & Therapy
53. Acetyl-CoA the Key Factor for Survival or Death of Cholinergic Neurons in Course of Neurodegenerative Diseases
    Andrzej Szutowicz, Hanna Bielarczyk, Agnieszka Jankowska-Kulawy, Tadeusz Pawełczyk, Anna Ronowska · 2013 · Neurochemical Research
54. Cystatin C in Alzheimer's disease
    Kaur, Gurjinder, Levy, Efrat · 2012 · Frontiers in Molecular Neuroscience
55. The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
    Benjamin L. Handen, Ira T. Lott, Bradley T. Christian, Nicole Schupf, Sid E. O’Bryant, Mark E. Mapstone, Anne M. Fagan, Joseph Hyungwoo Lee, Dana Tudorascu, Mei‐Cheng Wang et al. · 2020 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
56. Frequent Truncating Mutation of TFAM Induces Mitochondrial DNA Depletion and Apoptotic Resistance in Microsatellite-Unstable Colorectal Cancer
    Jianhui Guo, Zheng Li, Wenyong Liu, Xianshu Wang, Zehua Wang, Zehua Wang, Amy J. French, Dongchon Kang, Lin Chen, Stephen N. Thibodeau et al. · 2011 · Cancer Research
57. Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer’s disease
    Xu, Jielin, Mao, Chengsheng, Hou, Yuan, Luo, Yuan, Binder, Jessica L., Zhou, Yadi, Bekris, Lynn M., Shin, Jiyoung, Hu, Ming, Wang, Fei et al. · 2022 · Cell Reports
58. PDX1 deficiency causes mitochondrial dysfunction and defective insulin secretion through TFAM suppression
    Gauthier, Benoit R., Wiederkehr, Andreas, Baquié, Mathurin, Dai, Chunhua, Powers, Alvin C., Kerr-Conte, Julie, Pattou, François, MacDonald, Raymond J., Ferrer, Jorge, Wollheim, Claes B. · 2009 · Cell Metabolism
59. A Gene Expression Pattern in Blood for the Early Detection of Alzheimer's Disease
    Birgitte Boonstra Booij, Torbjørn Lindahl, Peter Wetterberg, Nina V. Skaane, Solve Sæbø, Guri Feten, Philip D. Rye, Lena Kristiansen, Nina Hagen, Marianne Jensen et al. · 2011 · Journal of Alzheimer s Disease
60. De-regulation of gene expression and alternative splicing affects distinct cellular pathways in the aging hippocampus
    Roman Manuel Stilling, Eva Benito, Jonas Barth, Michael Gertig, Vincenzo Capece, Susanne Burckhardt, Stefan Bonn, André Fischer · 2014 · Frontiers in Cellular Neuroscience
61. Insulin-Degrading Enzyme: Structure-Function Relationship and its Possible Roles in Health and Disease
    Agata C Fernández-Gamba, M. Leal, Laura Morelli, E. Castano · 2009 · Current Pharmaceutical Design
62. Genetics of Alzheimer disease in the pre- and post-GWAS era
    Nilüfer Ertekin‐Taner · 2010 · Alzheimer s Research & Therapy
63. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations
    Jean‐Charles Lambert, Diana Zélénika, Mikko Hiltunen, Vincent Antoine Chouraki, Onofre Combarros, Maria Jesus Bullido, Gloria Tognoni, Nathalie Fiévet, Anne Boland, Beatrice Arosio et al. · 2011 · Neurobiology of Aging
64. Comprehensive Field Synopsis and Systematic Meta-analyses of Genetic Association Studies in Cutaneous Melanoma
    Foteini Chatzinasiou, Christina M. Lill, Katerina P. Kypreou, Irene Stefanaki, V. Nicolaou, George M. Spyrou, Εvangelos Εvangelou, Johannes T. Roehr, Elisavet Kodela, A Katsambas et al. · 2011 · JNCI Journal of the National Cancer Institute
65. Effect of BDNF Val66Met on Memory Decline and Hippocampal Atrophy in Prodromal Alzheimer’s Disease: A Preliminary Study
    Lim, Yen Ying, Villemagne, Victor L., Laws, Simon M., Ames, David, Pietrzak, Robert H., Ellis, Kathryn A., Harrington, Karra, Bourgeat, Pierrick, Bush, Ashley I., Martins, Ralph N. et al. · 2014 · PLoS ONE
66. Toward the Treatment and Prevention of Alzheimer's Disease: Rational Strategies and Recent Progress
    Gandy, Sam, DeKosky, Steven T. · 2013 · Annual Review of Medicine
67. Identification and estimation of survivor average causal effects
    Eric J. Tchetgen Tchetgen · 2014 · Statistics in Medicine
68. Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition
    Mohammad Hassan Baig, Khurshid Ahmad, Gulam Rabbani, Inho Choi · 2018 · Frontiers in Aging Neuroscience
69. The Endolysosomal System and Proteostasis: From Development to Degeneration
    Bettina Winckler, Victor Faúndez, Sandra Maday, Qian Cai, Cláudia Guimas Almeida, Huaye Zhang · 2018 · Journal of Neuroscience
70. The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
    Franzmeier, Nicolai, Rubinski, Anna, Neitzel, Julia, Ewers, Michael, The Alzheimer’s Disease Neuroimaging Initiative (ADNI), Weiner, Michael W., Aisen, Paul, Petersen, Ronald, Jack, Clifford R., Jagust, William et al. · 2019 · Nature Communications
71. The application of naive Bayes model averaging to predict Alzheimer's disease from genome-wide data
    Wei Wei, Shyam Visweswaran, Gregory F. Cooper · 2011 · Journal of the American Medical Informatics Association
72. Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics
    Yogatheesan Varatharajah, Vijay K. Ramanan, Ravishankar K. Iyer, Prashanthi Vemuri, Alzheimer’s Disease Neuroimaging Initiative, Michael Walter Weiner, Paul Aisen, Ronald Carl Petersen, Clifford R. Jack, Andrew J. Saykin et al. · 2019 · Scientific Reports
73. Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases
    Catherine M. Cahill, Debomoy K. Lahiri, Xudong Huang, Jack T. Rogers · 2008 · Biochimica et Biophysica Acta (BBA) - General Subjects
74. Role of genes linked to sporadic Alzheimer’s disease risk in the production of β-amyloid peptides
    Bali, Jitin, Gheinani, Ali Hashemi, Zurbriggen, Sebastian, Rajendran, Lawrence · 2012 · Proceedings of the National Academy of Sciences
75. Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape
    Antero Salminen, Annakaisa Haapasalo, Anu Kauppinen, Kai Kaarniranta, Hilkka S. Soininen, Mikko O. Hiltunen · 2015 · Progress in Neurobiology
76. Systemic and Acquired Immune Responses in Alzheimer's Disease
    Markus Britschgi, Tony Wyss‐Coray · 2007 · International review of neurobiology
77. Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review
    Inga Kuhlmann, Anne Marie Minihane, Patricia Huebbe, Almut Nebel, Gerald H Rimbach · 2010 · Lipids in Health and Disease
78. A Review of Genetic Association Studies of Obstructive Sleep Apnea: Field Synopsis and Meta-Analysis
    Varvarigou, Vasileia, Dahabreh, Issa J., Malhotra, Atul, Kales, Stefanos N. · 2011 · Sleep
79. Alzheimer's disease genetics: current knowledge and future challenges
    Paul Hollingworth, Denise H. Harold, Lesley Jones, Michael John Owen, Julie H. Williams · 2010 · International Journal of Geriatric Psychiatry
80. SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer' Disease: The Role of the Immune System in Clearance of Aβ from the Brain
    Delphine Boche, James A. R. Nicoll · 2008 · Brain Pathology
81. Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis
    Kristiina Rannikmäe, Neshika Samarasekera, Nahara Anani Martínez-González, Rustam Al‐Shahi Salman, Cathie L. M. Sudlow · 2013 · Journal of Neurology Neurosurgery & Psychiatry
82. Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy school-aged children and throughout adulthood? Evidence from clinical trials
    Stonehouse, Welma · 2014 · Nutrients
83. Whole-genome sequencing reveals new Alzheimer’s disease–associated rare variants in loci related to synaptic function and neuronal development
    Prokopenko, Dmitry, Morgan, Sarah L., Mullin, Kristina, Hofmann, Oliver, Chapman, Brad, Kirchner, Rory, Alzheimer's Disease Neuroimaging Initiative (ADNI), Amberkar, Sandeep, Wohlers, Inken, Lange, Christoph et al. · 2021 · Alzheimer's & Dementia
84. Identification of Differentially Expressed Genes through Integrated Study of Alzheimer’s Disease Affected Brain Regions
    Nisha Puthiyedth, Carlos Riveros, Regina Esther Berretta, Pablo Moscato · 2016 · PLoS ONE
85. BACE1 Retrograde Trafficking Is Uniquely Regulated by the Cytoplasmic Domain of Sortilin
    Finan, Gina M., Okada, Hirokazu, Kim, Tae-Wan · 2011 · Journal of Biological Chemistry
86. The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers
    Nadine D. Younan, Claire J. Sarell, Paul Davies, David R. Brown, John H. Viles · 2013 · The FASEB Journal
87. Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies
    Michael Vaclav Holmes, Tina Shah, Christine Vickery, Liam L Smeeth, Aroon Dinesh Hingorani, Juan Pablo Casas · 2009 · PLoS ONE
88. Extended tracts of homozygosity identify novel candidate genes associated with late-onset Alzheimer’s disease
    Mike A. Nalls, Rita João Guerreiro, Javier Simón‐Sánchez, José Brás, Bryan J. Traynor, Jesse Raphael Gibbs, Lenore J. Launer, John Hardy, Andrew Singleton · 2009 · Neurogenetics
89. Genetics of Alzheimer’s Disease
    Perry G. Ridge, Mark Ebbert, John S. K. Kauwe · 2013 · BioMed Research International
90. Proteomic identification of sorting nexin 6 as a negative regulator of BACE1‐mediated APP processing
    Okada, Hirokazu, Zhang, Wenzhu, Peterhoff, Corrinne, Hwang, Jeremy C., Nixon, Ralph A., Ryu, Sung H., Kim, Tae‐Wan · 2010 · The FASEB Journal
91. Functional MRI Assessment of Task-Induced Deactivation of the Default Mode Network in Alzheimer’s Disease and At-Risk Older Individuals
    Pihlajamäki, Maija, Sperling, Reisa A. · 2009 · Behavioural Neurology
92. Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer’s disease. A meta-analysis
    Saeed Sadigh‐Eteghad, Mahnaz Talebi, Mehdi Farhoudi · 2012 · Neurosciences
93. Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk
    Fabian W. Corlier, George W. Hafzalla, Joshua Faskowitz, Lewis H. Kuller, James T. Becker, Oscar L. López, Paul M. Thompson, Meredith N. Braskie · 2018 · NeuroImage
94. The Role of Clusterin, Complement Receptor 1, and Phosphatidylinositol Binding Clathrin Assembly Protein in Alzheimer Disease Risk and Cerebrospinal Fluid Biomarker Levels
    Brit‐Maren M. Schjeide, Cathrin Schnack, Jean‐Charles Lambert, Christina M. Lill, Julia Kirchheiner, Hayrettin Tumani, Markus Otto, Rudolph E. Tanzi, Hans Lehrach, Philippe Amouyel et al. · 2011 · Archives of General Psychiatry
95. Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies
    López González, Irene, Garcia-Esparcia, Paula, Llorens, Franc, Ferrer, Isidre · 2016 · International Journal of Molecular Sciences
96. Lipid metabolism in Alzheimer’s disease
    Liu, Qiang, Zhang, Juan · 2014 · Neuroscience Bulletin
97. Keeping up with genetic discoveries in amyotrophic lateral sclerosis: The ALSoD and ALSGene databases
    Christina M. Lill, Olubunmi Abel, Lars Bertram, Ammar Al‐Chalabi · 2011 · Amyotrophic Lateral Sclerosis
98. Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease
    Judes Poirier, Justin Miron, Cynthia Picard, Patrick Gormley, Louise Théroux, John C.S. Breitner, Doris Dea · 2014 · Neurobiology of Aging
99. Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice
    Christian Griñán‐Ferré, Sara Sarroca, Aleksandra Ivanova, Dolors Puigoriol‐Illamola, Fernando Aguado, Antoni Camins, Coral Sanfeliu, Mercè Pallàs · 2016 · Aging
100. Meta‐analyses identify differentially expressed microRNAs in Parkinson's disease
     Jessica Schulz, Petros Takousis, Inken Wohlers, Ivie Itua, Valerija Dobričić, Gerta Rücker, Harald Binder, Lefkos T. Middleton, John P. A. Ioannidis, Robert Perneczky et al. · 2019 · Annals of Neurology